Literature DB >> 7817222

Behavioural change amongst drug injectors in Scottish prisons.

D Shewan1, M Gemmell, J B Davies.   

Abstract

A study of injecting behaviour amongst a purposive sample of drug-users in Scottish prisons found that 32% reported injecting prior to current sentence. The percentage of these who were injecting during their current prison sentence (i.e. inside the prison) had fallen to 11%. Of those who were injecting prior to imprisonment, 24% reported sharing injecting equipment at that time. Of those who were still injecting in prison, however, 76% reported sharing equipment. Overall, therefore, there were fewer injectors in prison, but a higher proportion of these shared needles. Factors most closely identified with current sharing of injecting equipment in prison were: (a) having injected a wider range of drugs in prison (during both current and previous sentences); (b) frequency of Temgesic use; and (c) being prescribed methadone in the community, then having that prescription discontinued on entry to prison.

Entities:  

Mesh:

Year:  1994        PMID: 7817222     DOI: 10.1016/0277-9536(94)90010-8

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  6 in total

1.  Ethical and human rights imperatives to ensure medication-assisted treatment for opioid dependence in prisons and pre-trial detention.

Authors:  R Douglas Bruce; Rebecca A Schleifer
Journal:  Int J Drug Policy       Date:  2008-01-15

2.  Coinfections by HIV, hepatitis B and hepatitis C in imprisoned injecting drug users.

Authors:  J R Pallás; C Fariñas-Alvarez; D Prieto; M Delgado-Rodríguez
Journal:  Eur J Epidemiol       Date:  1999-09       Impact factor: 8.082

Review 3.  HIV and the criminalisation of drug use among people who inject drugs: a systematic review.

Authors:  Kora DeBeck; Tessa Cheng; Julio S Montaner; Chris Beyrer; Richard Elliott; Susan Sherman; Evan Wood; Stefan Baral
Journal:  Lancet HIV       Date:  2017-05-14       Impact factor: 12.767

Review 4.  Injectable and implantable sustained release naltrexone in the treatment of opioid addiction.

Authors:  Nikolaj Kunøe; Philipp Lobmaier; Hanh Ngo; Gary Hulse
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

5.  Consumption of psychoactive substances in prison: Between initiation and improvement, what trajectories occur after incarceration? COSMOS study data.

Authors:  Morgane Rousselet; Marylène Guerlais; Pascal Caillet; Bertrand Le Geay; Damien Mauillon; Patrick Serre; Pierre-Yves Chameau; Yves Bleher; Serge Mounsande; Pascale Jolliet; Caroline Victorri-Vigneau
Journal:  PLoS One       Date:  2019-12-04       Impact factor: 3.240

6.  Elevated HIV risk behaviour among recently incarcerated injection drug users in a Canadian setting: a longitudinal analysis.

Authors:  M-J S Milloy; Jane Buxton; Evan Wood; Kathy Li; Julio S G Montaner; Thomas Kerr
Journal:  BMC Public Health       Date:  2009-05-27       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.